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ABSTRACT 
PEX1 and PEX6 are two members of the 
ATPases Associated with diverse cellular 
Activities (AAA) family and the core 
components of the receptor export module 
(REM) of the peroxisomal matrix protein import 
machinery. Their role is to extract 
monoubiquitinated PEX5, the peroxisomal 
protein shuttling receptor, from the peroxisomal 
membrane docking/translocation module 
(DTM), so that a new cycle of protein 
transportation can start. Recent data have shown 
that PEX1 and PEX6 form a heterohexameric 
complex which unfolds substrates by processive 
threading. However, whether the natural 
substrate of the PEX1.PEX6 complex is 
monoubiquitinated PEX5 (Ub-PEX5) itself or 
some Ub-PEX5-interacting component(s) of the 
DTM remains unknown. In this work, we used 
an established cell-free in vitro system coupled 
with photoaffinity crosslinking and protein 
PEGylation assays to address this problem. We 
provide evidence suggesting that DTM-
embedded Ub-PEX5 interacts directly with both 
PEX1 and PEX6 through its ubiquitin moiety 
and that the PEX5 polypeptide chain is globally 
unfolded during the ATP-dependent extraction 
event. These findings strongly suggest that 
DTM-embedded Ub-PEX5 is a bona fide 
substrate of the PEX1.PEX6 complex.  
 
INTRODUCTION 
Peroxisomes are cytoplasmic organelles 
delimited by a single membrane found in almost 
all eukaryotes (1). In mammals, they harbor a set 
of approximately 100 different proteins and are 
involved in several metabolic pathways such as 
β-oxidation of fatty acids, synthesis of 
plasmalogens and bile acids, and detoxification 
of glyoxylate (2–6). Despite their simplicity, 
peroxisomes play important roles in human 
health and development, as demonstrated by a 
group of inherited metabolic disorders in which 
peroxisomes are partially or even completely 
defective, the peroxisomal biogenesis disorders 
(7). These diseases are caused by mutations in 
genes encoding proteins mechanistically 
involved in several aspects of peroxisome 
biogenesis – the so-called peroxins or PEX 
proteins (6–8). In mammals 16 peroxins are 
presently known, 10 of which are components of 
the machinery that sorts newly synthesized 
proteins to the organelle matrix (reviewed in 
(9)). 
 Proteins destined to the peroxisomal 
matrix are synthesized in the cytosol and 
transported to the organelle membrane by PEX5, 
the peroxisomal matrix protein shuttling receptor 
(10–20). There, cargo-loaded PEX5 interacts 
with the docking/translocation module (DTM), a 
multisubunit transmembrane complex 
comprising the core components PEX2, PEX10, 
PEX12, PEX13 and PEX14 (21, 22). This 
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interaction culminates with the insertion of 
PEX5 into the DTM with the concomitant 
translocation and release of the cargo protein 
into the organelle matrix (23–26). No ATP 
hydrolysis or a membrane potential is needed for 
these steps; the driving force for the complete 
cargo transport process resides in the strong 
protein-protein interactions that are established 
between PEX5 and DTM components (23, 25, 
27). 
 After releasing its cargo, PEX5 has to be 
extracted from the DTM so that a new protein 
transport cycle can be initiated. Recycling of 
PEX5 involves three steps. First, DTM-
embedded PEX5 is monoubiquitinated at a 
conserved cysteine residue (Cys11 in the human 
protein) (28, 29). Then, monoubiquitinated 
PEX5 (Ub-PEX5) is extracted into the cytosol in 
an ATP hydrolysis-dependent manner by the so-
called receptor export module (REM) (27, 30, 
31). This is a protein complex comprising PEX1 
and PEX6, two members of the AAA ATPases 
family, plus a poorly conserved peroxisomal 
membrane protein (PEX26 in mammals, 
APEM9 in plants, or PEX15 in yeasts/fungi) 
which anchors the ATPases to the organelle 
membrane (32–34). Finally, Ub-PEX5 is 
deubiquitinated in the cytosol probably by a 
combination of enzymatic and non-enzymatic 
events (35–37). 
Although the general properties of the 
PEX5-mediated protein import pathway are 
known, the mechanistic details of each of its 
steps remain mostly unclear. In this work, we 
focused on the mechanism used by the REM to 
extract Ub-PEX5 from the DTM.  
An abundance of structural/functional 
data was recently reported for the yeast REM. 
These include electron microscopy structures of 
the PEX1.PEX6 complex, an X-ray structure of 
the cytosolic domain of PEX15, and the 
structure of a trimeric complex containing these 
three proteins (reviewed in (38); (39–42)). These 
studies revealed that PEX1 and PEX6 assemble 
into a ring-shaped heterohexameric complex, 
best described as a trimer of PEX1.PEX6 
heterodimers, displaying a relatively large pore 
at its center. These data, together with 
mutational analyses of PEX1 and PEX6 showing 
that the conserved hydrophobic residues of the 
so-called pore loops are important for 
PEX1.PEX6 function, might suggest that the 
PEX1.PEX6 complex uses its pore to handle 
substrates (39, 40, 42). Robust data showing that 
the PEX1.PEX6 complex indeed unfolds 
substrates in a pore loop-dependent manner 
using a processive threading mechanism were 
reported very recently (42). Surprisingly, the 
unfolding/threading activity of the PEX1.PEX6 
complex was detected using a soluble fragment 
of PEX15 as substrate, but whether or not 
PEX15 is a natural substrate for these ATPases 
remains unknown, as thoroughly discussed by 
the authors of that work ((42); see also 
Discussion). 
Here, we asked whether or not DTM-
embedded Ub-PEX5 displays properties of a 
bona fide REM substrate. Our data shows that 
DTM-embedded Ub-PEX5 interacts directly 
with PEX1.PEX6 and is globally unfolded 
during the ATP-dependent extraction step. This 
suggests that Ub-PEX5 is indeed a natural 
substrate of the REM. 
 
RESULTS 
The results reported below were 
obtained with a cell-free in vitro system that 
recapitulates all the steps of the PEX5-mediated 
protein import pathway. This experimental 
system was thoroughly described recently (43) 
but a brief explanation is provided here for 
clarity. The core of the system is a rat liver post-
nuclear supernatant (PNS; the source of 
peroxisomes and cytosolic proteins), which is 
incubated with an in vitro synthesized 
radiolabeled PEX5 protein under appropriate 
conditions. During this incubation, a fraction of 
the radiolabeled PEX5 protein becomes inserted 
into the peroxisomal DTM, where it is 
subsequently monoubiquitinated at cysteine 11, 
and rapidly exported into the cytosol by the 
REM in an ATP-dependent manner. A number 
of strategies can be used to block this pathway 
(43). For instance, AMP-PNP and ATPγS, two 
ATP analogs used in this work, are excellent 
substrates for the ubiquitin-conjugating cascade 
(36, 44) but potent inhibitors of the REM (36). 
Thus, in vitro assays containing one of these 
nucleotides will reveal an accumulation of Ub-
PEX5 at the peroxisomal DTM, particularly so if 
the PNS was previously “primed”, i.e., pre-
incubated with a small amount of ATP to release 
endogenous PEX5 from the DTMs (25). Two 
types of in vitro assays are used here: the so-
called single-step and the two-step import/export 
assays. The first involves a single incubation of 
the reaction mixture. If such an assay is 
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performed in the presence of ATP then all the 
steps of the pathway will occur, i.e.,  
radiolabeled PEX5 will continuously interact 
with the DTM, where it is monoubiquitinated 
and subsequently exported into the soluble phase 
of the assay. Thus, if at the end of the incubation 
period the PNS is centrifuged to separate 
organelles from soluble proteins, most 
monoubiquitinated PEX5 will be detected in the 
soluble fraction. In the two-step import/export 
assay, a radiolabeled PEX5 protein is first 
accumulated at the DTM in the presence of 
AMP-PNP or ATPγS (the first step of the assay); 
the organelles are then isolated by 
centrifugation, ressuspended and incubated in 
buffer containing ATP (the second step), to 
allow export of the Ub-PEX5 protein into the 
soluble phase of the assay (36). The two-step 
assay is particularly suited to characterize events 
downstream of the monoubiquitination step. For 
practical reasons related to the lability of the 
thiol ester bond linking ubiquitin to cysteine 11 
of PEX5 (29), all the PEX5 proteins used in this 
work contain instead a lysine at position 11. 
These C11K mutants are fully functional both in 
vitro and in vivo (35), but the corresponding 
monoubiquitinated forms are much more 
resistant upon SDS-PAGE, which can be 
performed under reducing conditions.  Also, 
many of the experiments described here were 
performed with a truncated protein comprising 
amino acid residues 1-324 of PEX5 and 
derivatives of it. This protein lacks the globular 
tetratricopeptide-repeat domain of PEX5 and 
thus is unable to bind efficiently PTS1-
containing proteins. However, all the other 
functions of the receptor are preserved in this C-
terminal truncated species (45).  Finally, two 
read-outs are possible in these assays. One, a 
protease-protection assay, explores the fact that 
PEX5, or truncated versions of it, are extremely 
sensitive to proteases, such as proteinase K, 
unless they are inserted into the DTM. In the 
other, no protease-treatment is performed - one 
just monitors the distribution of 
monoubiquitinated PEX5 species between the 
organelle and soluble fractions of the assay by 
SDS-PAGE/autoradiography. It is important to 
note that in the latter case, large amounts of non-
ubiquitinated PEX5 species will be detected in 
the organelle pellets. Although a fraction of this 
material represents non-ubiquitinated PEX5 
specifically interacting with the DTM, the 
majority may represent PEX5 protein non-
specifically adsorbed to the organelles, some of 
which may even appear in the supernatant 
fraction of a two-step assay. Thus, no 
conclusions are drawn from the behavior of 
these non-ubiquitinated PEX5 species.      
Neither the N- nor the C-terminus of DTM-
embedded Ub-PEX5 is important for the 
export step. 
Many members of the AAA family of 
mechanoenzymes explore the presence of 
extended N- or C-termini in their substrates to 
unfold or pull them out of protein complexes 
(46, 47). For instance, katanin, a member of the 
AAA microtubule-severing family, extracts 
tubulin from microtubules by grabbing and 
pulling its disordered C-terminal tail (48, 49). As 
a first step to understand how Ub-PEX5 is 
dislocated from the DTM, we asked whether a 
similar mechanism might be valid for the 
peroxisomal REM.  
We know from previous work that no 
particular C-terminal domain of PEX5 is 
important for the dislocation process because 
truncated proteins comprising amino acid 
residues 1-324, 1-197 or 1-125 of PEX5 are all 
functional in the dislocation step  (45, 50). Also, 
we have recently shown that a PEX5 protein 
possessing an enhanced GFP (EGFP) moiety at 
its C-terminus is still a substrate for the 
dislocation machinery (51). Indeed, although 
that PEX5-EGFP fusion protein was not 
efficiently released from the DTM, protease 
protection assays revealed that most of the 
protein that accumulated at the peroxisome in 
the presence of ATP was already largely 
exposed into the cytosol, indicating that the C-
terminal EGFP moiety interferes with the 
dislocation machinery only at late stages of the 
extraction process. Additional data indicating 
that the presence of an unrelated protein domain 
at the C-terminus of a PEX5 protein does not 
interfere with the dislocation process were 
obtained when a 
35
S-labeled fusion protein 
comprising the first 324 amino acid residues of 
PEX5 fused to ubiquitin lacking its last two 
glycine residues (PEX5(1-324;C11K)-Ub(1-74); 
see Fig. 1 for a schematic representation of the 
PEX5 proteins used in this work) was used in a 
cell-free in vitro two-step import/export assay 
(36). Similarly to 
35
S-labeled PEX5(1-
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324;C11K), used here as a positive control (Fig. 
2A, two lower panels; (36)), monoubiquitinated 
PEX5(1-324;C11K)-Ub(1-74) was efficiently 
dislocated into the soluble phase of the reaction 
when ATP (but not AMP-PNP) was used in the 
second step of the assay. Identical results were 
obtained with a similar PEX5 protein in which 
mouse dehydrofolate reductase (DHFR) was 
substituted for Ub(1-74) (see later). Thus, we 
next focused on the N-terminus of PEX5.  
DTM-embedded PEX5 exposes a 2 to 3-
kDa domain from its N-terminus into the cytosol 
(45, 52). This small domain comprises cysteine 
11, the residue that has to be monoubiquitinated 
so that PEX5 can be extracted by the REM. 
Thus, the REM might extract Ub-PEX5 from the 
DTM by interacting with its first 10 amino acid 
residues. To test this, we produced a protein 
comprising amino acid residues 10 to 324 of 
PEX5 (PEX5(10-324;C11K)) and assessed the 
capacity of this protein to enter the DTM, be 
monoubiquitinated and extracted back into the 
cytosol using a single-step in vitro import/export 
assay. As shown in Fig. 2B, the amounts of 
monoubiquitinated PEX5(10-324;C11K) and 
PEX5(1-324;C11K) detected in the supernatants 
of the reactions made in the presence of ATP are 
similar. Taken together, these data suggest that if 
the REM recognizes DTM-embedded Ub-PEX5 
through a direct interaction, this interaction does 
not involve a free disordered N- or C-terminal 
end on PEX5.  
 
DTM-embedded Ub-PEX5 can be crosslinked 
to both PEX1 and PEX6 through its ubiquitin 
moiety. 
DTM-embedded PEX5 can only be 
exported back into the cytosol after 
monoubiquitination at its Cys11 residue. Thus, 
in principle, the ubiquitin moiety attached to 
PEX5 might interact with the REM. However, 
experimental evidence supporting this possibility 
is still lacking. We note that there are some data 
suggesting that both non-ubiquitinated and 
monoubiquitinated PEX5 interact with AWP1, a 
cytosolic protein reported to bind PEX6 and 
seemingly necessary for the export step (53). 
However, AWP1 does not interact with the 
PEX1.PEX6 protein complex, the active form of 
the REM (53), and thus the exact role of AWP1 
in the dislocation process remains undefined.  
Aiming at better understanding the role 
of ubiquitin in PEX5 dislocation, we used a 
photocrosslinking approach (54, 55) to identify 
the molecular neighbors of the ubiquitin moiety 
in the DTM-embedded Ub-PEX5 species. For 
this purpose four recombinant ubiquitin 
molecules, each harboring a photocrosslinking 
p-benzoyl-l-phenylalanine (pBpa) residue at a 
different position (see Fig. 3A), were produced 
and used in cell-free in vitro assays programmed 
with 
35
S-labeled PEX5(1-324;C11K) and 
performed in the presence of AMP-PNP. 
Organelle suspensions from these assays were 
then exposed to UV light, to elicit 
photocrosslinking, and subjected to SDS-
PAGE/autoradiography analyses. The results of 
these experiments are shown in Fig. 3B. In all 
cases, the most prominent UV-induced 
radiolabeled bands were detected in the high 
molecular weight region of the SDS-gel, 
suggesting that Ub-PEX5(1-324;C11K) 
(molecular mass of 45 kDa) was crosslinked to 
some large proteins, probably PEX1 and/or 
PEX6 (note that PEX1 and PEX6 are by far the 
two largest components of the peroxisomal 
protein import machinery displaying molecular 
masses of 141 and 104 kDa, respectively; (56–
58)).  
To determine whether or not PEX1 
and/or PEX6 are components of these 
crosslinked products, photocrosslinked 
organelles were solubilized in a denaturing SDS-
containing buffer and subjected to 
immunoprecipitation using either control IgGs or 
antibodies directed to PEX1 or PEX6. As shown 
in Fig. 3C, we were able to immunoprecipitate 
significant amounts of PEX1 without 
precipitating also PEX6, and vice-versa (see the 
two lower panels), showing that protein 
complexes were efficiently disrupted by the 
solubilization procedure. Autoradiography 
analyses of immunoprecipitates revealed that the 
main photocrosslinked products obtained with 
Ub(A28pBpa), Ub(D39pBpa), and 
Ub(Q49pBpa) comprise PEX6, whereas those 
obtained with Ub(Q62pBpa) contain PEX1. 
Clearly, the ubiquitin moiety of DTM-embedded 
Ub-PEX5(1-324;C11K) is very close to both 
PEX1 and PEX6, probably not more than a few 
Angstroms apart (59). Furthermore, the fact that 
Ub(Q62pBpa)-PEX5(1-324;C11K) reacts 
mainly with PEX1 whereas PEX5(1-324;C11K) 
modified with any of the other three pBpa-
modified ubiquitins reacts mainly with PEX6, 
suggests that the ubiquitin moiety in the DTM-
embedded Ub-PEX5 species does not wobble 
freely, but rather that it exists in a movement-
restricted location, i.e., in a binding site.  
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Extraction of Ub-PEX5 from the DTM 
involves/requires global unfolding of its 
polypeptide chain. 
As stated above, recent data suggest that 
both non-ubiquitinated and monoubiquitinated 
PEX5 somehow interact with REM components 
(53, 60). However, the mechanistic meaning of 
these interactions remains unknown. Given the 
recent demonstration that the yeast PEX1.PEX6 
complex uses a threading mechanism to unfold a 
substrate (42), we reasoned that assessing 
whether or not DTM-embedded Ub-PEX5 is 
globally unfolded during the extraction step 
would shed light on this issue.  
Two strategies were used for this 
purpose. In the first, we used the classical 
approach of fusing DHFR to a reporter protein 
that is used as the substrate in a process 
requiring unfolding of its polypeptide chain (61). 
This approach explores the fact that DHFR is a 
relatively pliable protein that can be unfolded by 
several molecular machineries, including 
ATPases of the AAA family (62, 63). However, 
this property changes completely in the presence 
of methotrexate (MTX), a folate analog that 
binds to DHFR greatly stabilizing its structure 
(64). We produced a fusion protein comprising 
the first 324 amino acid residues of 
PEX5(C11K) followed by mouse DHFR 
(PEX5(1-324;C11K)-DHFR) and used this 
protein, as well as PEX5(1-324;C11K), in two-
step in vitro import/export assays, which were 
done either in the presence or in the absence of 
MTX (see experimental procedures for details). 
As expected, MTX did not block export of 
monoubiquitinated PEX5(1-324;C11K); as 
shown in Fig. 4A (panel III), a considerable 
fraction of Ub-PEX5(1-324;C11K) was found in 
the soluble phase of the MTX-containing assay 
after incubation in the presence of ATP but not 
AMP-PNP (compare lanes 4 and 6; see also Fig. 
2A). A similar behavior was observed for Ub-
PEX5(1-324;C11K)-DHFR in the assay lacking 
MTX (Fig. 4A, panel I), although the export 
efficiency of this species seems to be already 
compromised (see legend to Fig. 4 for a 
quantification of export efficiencies). 
Importantly, in the presence of MTX and ATP, 
export of Ub-PEX5(1-324;C11K)-DHFR was 
strongly inhibited (Fig. 4A, panel II, compare 
lanes 4 and 6). Furthermore, under these 
conditions organelle-associated 
monoubiquitinated PEX5(1-324;C11K)-DHFR 
was mostly accessible to exogenously added 
proteinase K, indicating that the export step was 
blocked at a late stage (Fig. 4B). Thus, as 
previously described for a PEX5-EGFP fusion 
protein (51), the ATP-dependent dislocation of 
this species by the REM can be initiated but not 
terminated efficiently. Besides confirming that 
the identity of PEX5 C-terminus is irrelevant for 
the initiation of the extraction step, these 
findings indicate that an irrelevant protein 
domain appended to the C-terminus of the 
receptor inhibits its release by the REM, 
particularly if that domain is tightly folded.  
In the second approach we adapted an 
elegant assay recently developed for the yeast 
PEX1.PEX6 complex which monitors global 
unfolding of a protein substrate by determining 
the accessibility of its cysteine residues to 
maleimide-containing reagents (42). Full-length 
PEX5(C11K), which possesses 5 relatively 
unexposed cysteines at its C-terminal TPR 
domain ((65); see also Fig. 1), and PEG-
maleimide of 5 kDa were used in these 
experiments. Again, a two-step import/export 
protocol was used. Briefly, an organelle pellet 
containing DTM-embedded Ub-PEX5 was 
resuspended in import buffer and divided into 
three aliquots. One aliquot received ATPS, to 
maintain the REM blocked (29), plus PEG-
maleimide and was incubated for 3 min at 37 ºC. 
The second aliquot received PEG-maleimide 
plus a 2:1 ATP:ATPS mixture and was also 
incubated for 3 min at 37 ºC (note: ATP alone 
also works in this experiment (data not shown), 
but the PEGylation yields are slightly better with 
this mixture, presumably because it decreases 
the export rate); the third aliquot received the 2:1 
ATP:ATPS mixture, and after a 10 min-
incubation at 37 ºC (to release Ub-PEX5 into the 
soluble phase of the assay) was treated for an 
additional 3 min at 37 ºC with PEG-maleimide. 
After quenching unreacted PEG-maleimide with 
an excess of DTT, organelles and soluble 
proteins were then separated by centrifugation 
and both were analyzed by SDS-
PAGE/autoradiography. As shown in Fig. 5, Ub-
PEX5 arrested at the DTM (lane 2) was not 
PEGylated whereas only a small fraction of 
already released (soluble) Ub-PEX5 (lane 7) was 
PEGylated during the 3-min incubation. In 
contrast, the presence of PEG-maleimide during 
the 3-min export step led to an almost 
quantitative PEGylation of Ub-PEX5 (lane 5). 
Altogether, these data strongly suggest that 
extraction of Ub-PEX5 from the peroxisomal 
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DTM involves unfolding of its polypeptide 
chain.  
 
DISCUSSION 
It is long known that extraction of Ub-
PEX5 from the peroxisomal DTM is an ATP-
dependent process that requires the AAA 
ATPases PEX1.PEX6 (27, 30, 31) but how 
exactly this occurs has remained mysterious. A 
priori, and as discussed before (50), there are 
two possibilities: 1) the REM could interact with 
Ub-PEX5 and pull it from the DTM releasing it 
into the cytosol or 2) the REM could bind and 
unfold/sequester DTM components that interact 
with Ub-PEX5, thus disrupting all the 
interactions that maintain the receptor at the 
peroxisomal membrane. Although the first 
possibility is conceptually more straightforward, 
recent data on yeast and mammalian PEX1 and 
PEX6 proteins could actually support the second 
mechanism. We are referring to the fact that in 
vitro the yeast PEX1.PEX6 complex can bind 
and unfold a soluble fragment of PEX15, the 
yeast orthologue of mammalian PEX26, but not 
a linear ubiquitin-PEX5 fusion protein, and to 
the findings that both mammalian and yeast 
PEX1.PEX6 complexes interact with the 
PEX5.PEX14 complex via PEX26 and PEX15, 
respectively (42, 60). Together, these data might 
suggest that the interaction between PEX5 and 
PEX14, the main PEX5-binding component of 
the DTM, is disrupted by the PEX1.PEX6 
complex via PEX15/PEX26 (42). Although such 
a mechanism is plausible, the data supporting it 
can actually be interpreted differently. Indeed, as 
recently discussed by Gardner and colleagues 
(42), the interaction between PEX15/PEX26 and 
the PEX5.PEX14 complex may simply reflect a 
role of PEX15/PEX26 in recruiting Ub-PEX5 to 
the PEX1.PEX6 complex, and the fact that the 
yeast PEX1.PEX6 complex does not unfold a 
soluble linear ubiquitin-PEX5 fusion protein in 
vitro could mean that the AAA complex 
recognizes only correctly monoubiquitinated 
PEX5 (i.e., PEX5 ubiquitinated at its residue 11) 
or that the interaction between the PEX1.PEX6 
complex and PEX5 requires other peroxins, 
which were not present in those in vitro assays. 
Finally, the fact that yeast PEX1.PEX6 unfolds a 
C-terminally truncated PEX15 protein in vitro 
does not necessarily mean that it does so with 
full-length PEX15 in vivo, particularly when we 
consider that the free disordered C-terminal end 
of the recombinant PEX15 fragment engaged by 
the PEX1.PEX6 complex in those in vitro assays 
corresponds to an internal domain in the 
membrane embedded full-length PEX15 protein. 
Clearly, additional work was necessary to clarify 
this issue. 
Here, we used an established cell-free in 
vitro system to address this problem. We provide 
evidence strongly supporting the view that 
mammalian Ub-PEX5 is a bona fide substrate of 
the REM. Indeed, we found that DTM-
embedded Ub-PEX5 can be photocrosslinked to 
both PEX1 and PEX6. This suggests that Ub-
PEX5 interacts directly with the AAA ATPases 
of the REM, an expected property for an 
authentic substrate.  More importantly, we have 
shown that 1) PEX5 cysteine residues located 
dozens/hundreds residues apart from the 
pentapeptide motifs that mediate the interaction 
of PEX5 with the DTM (see Fig. 1) become 
largely exposed to a maleimide reagent during 
the ATP-dependent dislocation process, and 2) 
fusing the N-terminal half of PEX5 (a domain 
fully functional in both the import and export 
steps; (50)) to mouse DHFR results in a protein 
that arrests at the export step particularly when 
the stability of DHFR is increased by MTX. 
Thus, together, these results suggest that DTM-
embedded Ub-PEX5 undergoes global unfolding 
during the ATP-dependent extraction process, 
and that its unfolding is mandatory for a 
complete extraction from the organelle surface.  
Although it is still unclear how DTM-
embedded Ub-PEX5 is recruited to the 
translocation pore of the PEX1.PEX6 hexameric 
complex, the data presented here, together with 
previous findings, allow us to propose two 
hypothetical models. Both take into account that 
the minimal information necessary to engage the 
REM resides in the ubiquitin moiety itself plus 
the region comprising residues 10-125 of PEX5 
((45); and this work). In one model, a protein 
loop in the 10-125 region of PEX5 would enter 
the PEX1.PEX6 pore through its cis side (i.e., 
the membrane-facing side of the PEX1.PEX6 
complex). ATP hydrolysis would then lead to 
the translocation of the remaining Ub-PEX5 
domains through the REM pore, ultimately 
releasing the complete substrate into the cytosol, 
at the trans side of the PEX1.PEX6 complex. 
The rather large pore of the PEX1.PEX6 
complex, which may widen even more during 
substrate translocation, as proposed recently for 
CDC48 (66), together with the finding that 
PEX5(1-324;C11K)-Ub(1-74) displays no 
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detectable export problems (see Fig. 2A) might 
support this possibility.  
In the second model, the PEX1.PEX6 
ring would assemble around the short exposed 
segment of PEX5 that follows residue 11 (45). 
This would place this short segment of PEX5 
inside the pore and the ubiquitin moiety of Ub-
PEX5 already at the trans side of the 
PEX1.PEX6 complex. ATP hydrolysis would 
then lead to the complete dislocation of the 
PEX5 polypeptide chain into the cytosol. 
Discriminating between these two possibilities 
will be a challenging task, but the experimental 
tools and strategies developed in this work will 
surely help us to understand this and other still 
unclear aspects of the peroxisomal matrix 
protein import machinery. 
 
EXPERIMENTAL PROCEDURES 
DNA constructs. 
Plasmids encoding the large isoform of human 
PEX5 possessing a lysine instead of a cysteine 
residue at position 11 (pGEM4-PEX5(C11K); 
(35)), a C-terminally truncated form containing 
residues 1 to 324 (pET28-PEX5(1-324); (67)), a 
N-terminally truncated form containing residues 
315 to 639 (pQE30-PEX5(315-639); (68)), 
human UCHL3 (pET28a-UCHL3; (69)) and 
influenza hemagglutinin (HA)-tagged human 
Ubiquitin (pET28a-HA-Ub; (36)) were 
described previously. The plasmid pEVOL-
pBpF, which encodes the tRNA/tRNA 
synthetase pair necessary for the in vivo 
incorporation of the photocrosslinker pBpa, in 
response to an amber codon was a gift from 
Peter Schultz, USA ((54); Addgene plasmid # 
31190).    
The PEX5(1-324;C11K) cDNA, encoding amino 
acid residues 1 to 324 of PEX5(C11K) was 
obtained by PCR amplification of the plasmid 
pGEM4-PEX5(C11K) using the primers 5’-
GCCCAATACGCAAACCGCCTCTCC-3’ and 
5’-
GCGCGGATCCTCATTAGTACCCCTTATCA
TAGGTAGCTG-3’. The purified product was 
used directly in TNT
®
 quick-coupled 
transcription/translation reactions (see 
Miscellaneous). 
pGEM4-PEX5(10-324;C11K), a plasmid 
encoding residues 10 to 324 of PEX5(C11K) 
was obtained by PCR amplification of pGEM4-
PEX5(C11K) with primers 5’-
GGAATAAGTCGACATGGAAAAGGGGGGT
GC-3’ and 5’-
CGGGCAGGTCTAGATCAGTACCCCTTATC
ATAGGTAGC-3’. The purified product was 
digested and cloned into the SalI and XbaI sites 
of pGEM4 (Promega).  
A plasmid encoding residues 1 to 324 of 
PEX5(C11K) fused to the N-terminal of mouse 
DHFR was obtained as follows. First, DHFR 
coding region was amplified by PCR using the 
plasmid pYES2-cytb2(1-107)DHFR ((70); a 
kind gift of Dr. Dejana Mokranjac, Germany) 
and the primers 5’-
GCGCCGTCTAGAGGATCTGGGGTTCGAC
CATTGAACTGCATC-3’ and 
5’-
GCGCGCGGTACCTTAGTCTTTCTTCTCGT
AGACTTCAAAC-3’. The purified product was 
digested and cloned into the XbaI and KpnI sites 
of pGEM4 (Promega), originating pGEM4-
DHFR. Then, a DNA fragment encoding 
residues 1 to 324 of PEX5(C11K) was amplified 
from pGEM4-PEX5(C11K) by PCR with the 
primers 5’- 
GTCTGCCGGTCGACGCCACCATGGCAAT
GCGGGAGCTG-3’ and 
5’-
GCGCCGTCTAGATCCACTTCCGTACCCCT
TATCATAGGTAGCTGACG-3’. The purified 
fragment was digested and cloned into the 
SalI/XbaI-digest of pGEM4-DHFR, originating 
pGEM4-PEX5(1-324;C11K)-DHFR. 
To obtain a plasmid encoding residues 1 to 324 
of PEX5(C11K) fused to human ubiquitin 
lacking the two C-terminal Gly residues, a DNA 
fragment encoding residues 1 to 74 of ubiquitin 
was amplified from pET28a-HA-Ub using the 
primers 5’-
GCGTACTCTAGAAGCGGCATGCAGATCT
TCGTGAAGAC-3’ and 5’-
GCTCGCGGTACCTCATCTGAGACGGAGG
ACCAG-3’. The purified product was digested 
and cloned into the XbaI/KpnI-digest of 
pGEM4-PEX5(1-324;C11K)-DHFR, originating 
pGEM4-PEX5(1-324;C11K)-Ub(1-74). 
To generate a plasmid encoding HA-tagged 
ubiquitin with a C-terminal 6xHistidine-tag 
(pET28a-HA-Ub-His), the STOP codon of 
pET28a-HA-Ub was mutated by site-directed 
mutagenesis (QuikChange II site-directed 
mutagenesis kit; Agilent Technologies) using the 
primers 5’-
GTCTCAGAGGTGGTTCAGCGAATTCGAG
C-3’ and 5’-
GCTCGAATTCGCTGAACCACCTCTGAGA
C-3’. 
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Plasmids encoding HA-Ub-His harboring single 
amber codon mutations (A28X, D39X, Q49X or 
Q62X) were obtained by site-directed 
mutagenesis of pET28a-HA-Ub-His with the 
following primers: 5’-
GAGAATGTCAAGTAGAAGATCCAAGACA
AGGAAGGC-3’ and 5’-
GCCTTCCTTGTCTTGGATCTTCTACTTGA
CATTCTC-3’ for the A28X mutation; 5’-
GCATCCCTCCTTAGCAGCAGAGGTTGATC
-3’ and 5’-
GATCAACCTCTGCTGCTAAGGAGGGATG
C-3’ for the D39X mutation; 5’-
CTTTGCTGGGAAATAGCTGGAAGATGGA
CGC-3’ and 5’-
GCGTCCATCTTCCAGCTATTTCCCAGCAA
AG-3’ for the Q49X mutation; and 5’-
CTACAACATCTAGAAAGAGTCCACCCTG
C-3’ and 5’-
GCAGGGTGGACTCTTTCTAGATGTTGTAG
-3’ for the Q62X mutation.  
To obtain a plasmid encoding histidine-tagged 
residues 1 to 421 of human PEX6, the plasmid 
PTY03 (71) was digested with NcoI and the 
relevant fragment was cloned into the NcoI site 
of pET9dNHis6 (a kind gift of G. Stier. EMBL, 
Heidelberg; (72)). 
All generated plasmids were sequence-verified. 
 
Expression and purification of recombinant 
proteins 
The histidine-tagged proteins, PEX5(1-324), 
PEX5(315-639) (hereafter referred to as TPRs) 
and UCHL3 were purified as described 
previously (68, 69). All recombinant proteins 
were stored in Buffer A (50 mM Tris, pH 8.0, 
150 mM NaCl, 1 mM EDTA and 1 mM DTT). 
HA-Ub-His was expressed in Escherichia coli 
BL21(DE3) strain by induction with 1 mM 
isopropyl 1-thio-D-galactopyranoside for 3 h at 
37 ºC in LB medium. Pelleted cells were 
resuspended in lysis buffer (50 mM Tris, pH 7.4, 
150 mM NaCl, 1 mM DTT, 50 μg/mL PMSF, 
1:500 (v/v) protease inhibitor cocktail (cat. no. 
P8340, Sigma-Aldrich) and 200 μg/mL 
lysozyme), incubated on ice for 30 minutes and 
disrupted by sonication. Histidine-tagged 
proteins were purified by Ni Sepharose 6 Fast 
Flow affinity chromatography (GE Healthcare) 
according to manufacturer instructions. Proteins 
were concentrated and the buffer exchanged to 
Buffer A by repeated cycles of centrifugation 
and dilution using Vivaspin PES concentrator 
(MWCO 3000 Da, Sartorious). 
For incorporation of pBpa, HA-Ub-His amber 
mutants were expressed in BL21(DE3) cells 
carrying the plasmid pEVOL-pBpF. Induction 
was carried out for 3 h at 37 ºC with 1 mM 
isopropyl 1-thio-D-galactopyranoside and 0.02% 
arabinose in 2xYT media supplemented with 0.2 
mM pBpa (cat. no. F-2800; BACHEM). 
Purification was carried out as above. Histidine-
tags were removed from HA-Ub-His fusion 
proteins by digestion with the deubiquitinating 
enzyme UCHL3 (10 ng of UCHL3 per μg of 
HA-Ub-His protein; 1 h at 37 ºC). 
His-PEX6(1-421) was expressed in Escherichia 
coli BL21(DE3), and purified under denaturing 
conditions (8 M urea) by Ni-NTA 
chromatography (Qiagen) with refolding on the 
column following the manufacturer's 
instructions. 
 
In vitro peroxisomal import/export assays 
In vitro import/export assays of radiolabeled 
PEX5 proteins were performed as described 
previously (43). Briefly, 1 to 3 µL of 
35
S-labeled 
PEX5 proteins were used in reactions containing 
0.6 to 1 mg of a rat liver PNS primed for import 
(i.e., incubated for 5 min at 37 ºC in the presence 
of 0.4 mM ATP, to free DTMs of endogenous 
PEX5; (43)) in import buffer (20 mM MOPS-
KOH, pH 7.4, 0.25 M sucrose, 50 mM KCl, 3 
mM MgCl2, 20 µM methionine, 2 µg/mL E-64, 
2 mM reduced glutathione, 10 µM bovine 
ubiquitin, final concentration). Reactions were 
incubated at 37 ºC for 20 min in the presence of 
either 3 mM ATP or AMP-PNP. Reactions were 
then diluted with SEMK (20 mM MOPS-KOH, 
pH 7.4, 0.25 M sucrose, 1 mM EDTA-NaOH, 
pH 8.0, 80 mM KCl) and supernatant and 
organelle fractions were isolated by 
centrifugation at ~16.000 g for 15 min at 4 °C. 
Following protein precipitation with 10% (w/v) 
trichloroacetic acid, both fractions were 
analyzed by SDS-PAGE/Western-
blot/autoradiography. Where indicated, import 
reactions were treated with proteinase K exactly 
as described before (43). 
For the two-step assays, radiolabeled PEX5 
proteins were first imported in the presence of 3 
mM AMP-PNP (1
st
 step) and organelles were 
isolated as above. Organelle pellets were 
carefully resuspended in ice-cold import buffer 
(which in some experiments also contained 0.5 
µM BSA and 1 µM recombinant PEX5(1-324)), 
supplemented with either 3 mM ATP or AMP-
PNP and subjected to a second incubation (2
nd
 
8
 at U
N
IV
ERSID
A
D
E D
O
 PO
RTO
 on N
ovem
ber 2, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Ub-PEX5 is a substrate of the PEX1.PEX6 complex 
 
step) for 3 min at 37 ºC. Soluble and organelle 
fractions were isolated and analyzed by SDS-
PAGE/Western-blot/autoradiography, as 
described above. 
As required, import/export reactions were 
supplemented with: deubiquitinating-enzyme 
inhibitor ubiquitin-vinyl methyl ester (2 µM; 
(36)) to detect Ub-PEX5 in supernatants; 
recombinant TPRs (1 µM) to inhibit the import 
of rat endogenous PEX5 during import of C-
terminally truncated 
35
S-PEX5 species; and HA-
Ub (WT and pBpa containing mutants (10 µM) 
in substitution of bovine ubiquitin) for 
photocrosslinking experiments. MTX, used to 
impair the export of DHFR fusion PEX5, was 
added to reticulocyte lysates (pre-incubated for 
10 min at 25 ºC) and to import reactions at 2 
µM.  
 
Photocrosslinking and immunoprecipitation 
experiments 
For photocrosslinking experiments, import 
reactions of 
35
S-PEX5(1-324;C11K) were 
performed in the presence of 3 mM AMP-PNP 
and either HA-tagged wild-type or mutant 
ubiquitins containing a photoreactive pBpa 
residue. Following import (37 ºC for 30 min), 
reactions were halved and put on ice. One half 
was exposed to UV light (30 min on ice, Blak-
ray B-100AP 100W lamp, ~7 cm distance). 
Organelles from both halves were then isolated 
by centrifugation and analyzed by SDS-
PAGE/Western-blot/autoradiography, as 
previously described. 
To immunoprecipitate crosslinked products, 
organelle fractions of UV irradiated import 
reactions were solubilized in 50 mM Tris, pH 
8.0, 1 mM DTT, 1% SDS for 10 min at 65 ºC, 
and later diluted to RIPA buffer (50 mM Tris, 
pH 8.0, 150 mM NaCl, 1% Triton X-100, 0.5% 
DOC, 0.1% SDS, final concentration) 
supplemented with 1:200 (v/v) protease inhibitor 
cocktail. The lysate was clarified by 
centrifugation through a cellulose acetate 
membrane (Corning

 Costar

 Spin-X

 0.22 µm) 
and incubated (3 h at 4 ºC) with 50 µL (bed 
volume) of G protein-coupled sepharose pre-
loaded with either anti-PEX1, anti-PEX6 or 
control rabbit immunoglobulins.  Beads were 
then washed 3 times with 1 mL of RIPA buffer 
and once with 1 mL of Tris buffered saline (50 
mM Tris, pH 7.4, 150 mM NaCl). Bound 
proteins were eluted with Laemmli sample 
buffer. Total, unbound and 5 equivalents of 
bound protein fractions were subjected to SDS-
PAGE/Western blot and autoradiography. 
 
PEGylation susceptibility assays 
For the PEGylation assays, organelles derived 
from 
35
S-PEX5(C11K) import reactions made in 
the presence of 3 mM ATPγS were resuspended 
in import buffer containing either 3 mM ATPγS 
(export remains blocked) or a mixture of 2 mM 
ATP plus 1 mM ATPγS (export can occur). 
Methoxy-PEG-maleimide 5,000 Da (cat.no. 
63187, Sigma-Aldrich) was added at 4 mM 
(final concentration) either immediately before 
incubating at 37 ºC for 3 min, or after Ub-
PEX5(C11K) was exported into the soluble 
fraction by a 10 min incubation at 37 ºC. PEG-
maleimide was allowed to react only during 3 
min before quenching with 100 mM DTT (final 
concentration) for 3 min at 37 ºC. Reactions 
were diluted with ice-cold SEMK, centrifuged to 
isolate organelle and supernatant fractions, and 
processed for SDS-PAGE/Western-
blot/autoradiography. 
 
Miscellaneous 
35
S-Labeled proteins were synthesized in rabbit 
reticulocyte lysates using the TNT
®
 quick-
coupled transcription/translation system 
(Promega) in the presence of EasyTag
TM
 L-
[
35
S]methionine (specific activity, >1000 
Ci/mmol; PerkinElmer Life Sciences) following 
the manufacturer's instructions. 
The antibody against ABCD3 (73) was kindly 
provided by Dr. Wilhelm W. Just (University of 
Heidelberg, Germany). The anti-PEX6 antibody 
was raised in rabbit against human His-PEX6(1-
421). Rabbit Polyclonal Anti-PEX1 Antibody 
(NBP1-80577; Novus Biologicals) was 
purchased. All primary antibodies were detected 
with goat alkaline phosphatase-conjugated anti-
rabbit antibodies (A9919; Sigma-Aldrich). 
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FOOTNOTES 
The abbreviations used are: AAA, ATPases Associated with diverse cellular Activities; DHFR, 
dihydrofolate reductase; DTM, docking/translocation module; EGFP, enhanced GFP; HA, influenza 
hemagglutinin; MTX, methotrexate; pBpa, p-Benzoyl-l-Phenylalanine; PNS, post-nuclear 
supernatant; REM, receptor export module; Ub-PEX5, monoubiquitinated PEX5. 
 
FIGURE LEGENDS 
Figure 1. Schematic representation of PEX5 species used in this work. The C11K substitution, the 
PEX13- and PEX14-binding pentapeptide motifs (black bars; (74, 75)), the PEX7-binding domain 
(gray box; (76)), the PTS1-binding tetratricopeptide repeats (Zigzag boxes; (65)), and the 5 cysteine 
residues present in PEX5(C11K) (black dots) are indicated. Ub, ubiquitin; DHFR, dihydrofolate 
reductase. Abbreviated names of the different PEX5 species, as used throughout the figures, are 
shown in quotation marks. 
 
Figure 2. Neither the N- nor the C-terminus of DTM-embedded Ub-PEX5 is important for the 
export step. A, PEX5(1-324;C11K) containing a ubiquitin moiety at its C-terminus is extracted by 
the REM. Organelles from a PEX5(1-324;C11K)-Ub(1-74) (P5∆-Ub∆) or PEX5(1-324;C11K) (P5∆) 
import reaction made in the presence of AMP-PNP (PI; lane 1) were subjected to a second incubation 
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in the presence of either ATP, to promote export (lanes 2 and 3), or AMP-PNP to maintain the REM 
blocked (lanes 4 and 5). Organelle (PE; lanes 2 and 4) and soluble fractions (SE; lanes 3 and 5) were 
then analyzed by SDS-PAGE/Western-blot/autoradiography. A representative experiment (n=3) is 
shown. The distribution of the peroxisomal membrane protein ABCD3 is shown. Lane I, 5% of the 
indicated radiolabeled protein used in the assay. B, The first nine amino acid residues of PEX5 are not 
required for its export. Radiolabeled PEX5(10-324;C11K) (∆P5∆) or PEX5(1-324;C11K) (P5∆) were 
subjected to a single-step assay in the presence of either AMP-PNP or ATP, as indicated. Organelle 
pellets (P) and supernatants (S) were then analyzed by SDS-PAGE/Western-blot/autoradiography. A 
representative experiment (n=3) is shown. Immunoblot against ABCD3 is shown. *, unspecific 
proteins occasionally recognized by the ABCD3 antibody. Lanes I1 and I2, 10% of the indicated 
radiolabeled protein used in the assay. In A and B, numbers to the left indicate the molecular masses 
of protein standards in kDa. 
 
 
Figure 3. Monoubiquitinated PEX5(1-324;C11K) can be specifically photocrosslinked to PEX1 
and PEX6 through its ubiquitin moiety. A, Ubiquitin structure (PBD:1UBQ; (77)) highlighting the 
relative positions of the amino acid residues replaced by a photoreactive pBpa. B, Radiolabeled 
PEX5(1-324;C11K) (P5∆) was used in import assays containing AMP-PNP and either HA-tagged 
wild-type (WT) ubiquitin or one of four ubiquitin mutants possessing a single pBpa residue at the 
indicated position (A28, D39, Q49 or Q62). Import reactions were halved, and irradiated (30’ UV) or 
not (0’ UV) with UV light while kept on ice. Organelles were isolated by centrifugation and analyzed 
by SDS-PAGE/Western-blot/autoradiography. Lane I, 5% of the radiolabeled protein used in each 
reaction. Major crosslinking products are indicated. Some minor 
35
S-labeled crosslinked species were 
also detected; *. One of four experiments with similar results is shown. C, Organelle fractions of UV-
irradiated import reactions (as shown in B) were solubilized and immunoprecipitated with anti-PEX1 
(PEX1), anti-PEX6 (PEX6) or a rabbit control serum (Ctrl, control) in RIPA buffer. Total protein (T), 
immunoprecipitated protein (IP) and corresponding immunodepleted fractions (ID) were analyzed by 
SDS-PAGE/Western-blot/autoradiography. Each immunoprecipitation was performed at least twice.  
Following film exposure, the nitrocellulose membranes were cut slightly above the 116-kDa marker 
and the upper and lower strips were probed with anti-PEX1 and anti-PEX6 antibodies, respectively 
(the membrane from the Ub(Q62pBpa) experiment is shown here). In B and C, numbers to the left 
indicate the molecular masses of protein standards in kDa. 
 
Figure 4. A tightly folded domain appended to the C-terminal of PEX5(1-324;C11K) inhibits its 
export. A, Radiolabeled
 
PEX5(1-324;C11K)-DHFR (P5∆-DHFR) and PEX5(1-324;C11K) (P5∆) 
were used in two-step import/export assays carried out in the absence (panel I; -MTX) or presence of 
2 µM methotrexate (panels II and III; +MTX). After the import step, organelles (PI; lane 2) were 
separated from the cytosolic fraction (SI; lane 1) and subjected to the 2
nd
 step of the assay in the 
presence of either ATP (lanes 3 and 4) or AMP-PNP (lanes 5 and 6). Organelles (PE; lanes 3 and 5) 
and soluble fractions (SE; lanes 4 and 6) were analyzed by SDS-PAGE/Western-blot/ 
autoradiography. Autoradiographs and ABCD3 immunoblots are shown. SI, equivalent to 50 μg of 
PNS; PI, PE and SE, equivalent to 250 μg of PNS. Lane I, 25% of the radiolabeled protein used in the 
reactions. *, marks a N-terminally truncated product of PEX5(1-324;C11K)-DHFR that can be 
imported but not exported (78). The percentages of exported species (defined as the ratio of 
ubiquitinated species in SE to the sum of ubiquitinated species in SE and PE) were determined by 
densitometry analyses of three independent experiments. Values of 40% (range 26-47%), 10% (range 
7-13%), and 64% (range 53-82%) were obtained for Ub-P5∆-DHFR minus MTX, Ub-P5∆-DHFR 
plus MTX, and Ub-P5∆ plus MTX, respectively. B, Radiolabeled PEX5(1-324;C11K)-DHFR (P5∆-
DHFR) was subjected to single-step assays in the presence of MTX and either ATP or AMP-PNP. 
After incubation, samples were halved and treated (lanes +) or not (lanes -) with proteinase K (PK). 
Organelles were isolated and analyzed by SDS-PAGE/Western-blot/autoradiography. I, 5% of the 
radiolabeled protein used in the assay. The autoradiograph (upper panel) and the corresponding 
Ponceau S-stained membrane (lower panel) of a representative experiment (n=3) are shown. *, as in 
A. Numbers to the left indicate the molecular masses of protein standards in kDa. 
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Figure 5. Buried cysteine residues present in the C-terminal half of PEX5 become exposed 
during the export step. Full length PEX5(C11K) (P5) was subjected to import reactions in the 
presence of ATPγS. Isolated organelles (PI) were resuspended and used in three different export 
assays, performed in the presence of ATPγS (export blocked) or a 2:1 ATP:ATPγS mixture (export 
induced). PEG-maleimide 5,000 Da (PEG-mal) was added either immediately before or after Ub-
PEX5(C11K) (Ub-P5) export. PEGylation was done for 3 min at 37 ºC. Organelle (PE) and 
supernatant (SE) fractions were processed for SDS-PAGE/Western-blot/autoradiography. The 
autoradiograph (upper panel) and the corresponding Ponceau S-stained membrane (lower panel) of a 
representative experiment (n=3) are shown. Lane I, 2% of the radiolabeled protein used in the assay. 
Ub-P5-PEGn, PEGylated Ub-P5 species. Numbers to the left indicate the molecular masses of protein 
standards in kDa.  
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